45.5 F
New York
Sunday, November 29, 2020

Pluristem Therapeutics Inc. (NASDAQ:PSTI) on the Path to Profitability

Must read

Is the Rough Ride Over for TTM Technologies Inc. (TTMI)

TTM Technologies Inc. (TTMI) shares are trading at higher $13.25 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

The Last Few Sessions Have Tenable Holdings Inc. (TENB) Soaring

Tenable Holdings Inc. (TENB) shares are trading at higher $35.11 and the avg recommendation for the stock is Strong Buy, while the current analyst...

Renewed Optimism is Surrounding Polar Power Inc. (NASDAQ:POLA)

Polar Power Inc. (POLA) shares are trading at lower $4.96 and the avg recommendation for the stock is Moderate Buy. To add more color...

When Will The J. M. Smucker Company (SJM) Slow Down

The J. M. Smucker Company (SJM) shares are trading at higher $118.00 and the avg recommendation for the stock is Hold, while the current...

Pluristem Therapeutics Inc. (PSTI) shares are trading at higher $10.69 and the avg recommendation for the stock is Strong Buy.

To add more color to this target, the company’s high over the last year is $13.29 and the low is $2.82. Over the last 52 weeks, PSTI is down -19.56% while the S&P 500 is down -0.42%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

PSTI Return on Equity (ROE) is -165.80%, and its Return on Assets is -107.80%. All told, it is clear that, PSTI needs to be on your watchlist.

Find out when PSTI reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. PSTI has a short ratio of 1.89 and outstanding shares of 25.49M.

Company Outlook

PSTI has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.56 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -7.58. Pluristem Therapeutics Inc. PSTI also noted assets of $23.02 million at the end of the last quarter. Investors should also keep an eye on sector updates as PSTI has historically followed its peers on positive news.

All told, Pluristem Therapeutics Inc. PSTI has strung together solid data and demonstrated underlying fundamentals. At its current valuation, PSTI represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Pluristem Therapeutics Inc. PSTI is now commanding a market cap of 265.65M and a float of 20.07M. PSTI is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of PSTI stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in PSTI, either long or short, and we have not been compensated for this article.

Latest article

The Last Few Sessions Have Adial Pharmaceuticals Inc. (ADIL) Soaring

Adial Pharmaceuticals Inc. (ADIL) shares are trading at higher $1.89 and the avg recommendation for the stock is Moderate Buy. To add more color...

Boqii Holding Limited (NYSE:BQ) Stock is Soaring, Here is Why

Boqii Holding Limited (BQ) shares are trading at higher $6.08 and the avg recommendation for the stock is Moderate Buy. To add more color...

CIT Group Inc. (CIT)’s Stock is Jumping, Here is Why

CIT Group Inc. (CIT) shares are trading at lower $34.99 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Can We Expect More Volatility From Venator Materials PLC (VNTR)?

Venator Materials PLC (VNTR) shares are trading at lower $2.27 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

When Will CyrusOne Inc. (CONE) Slow Down

CyrusOne Inc. (CONE) shares are trading at higher $70.12 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...